Hematology Industry Mapping and Its Boundaries

Hematology Industry Mapping and Its Boundaries

Laboratory hematology is largely synonymous with its leading vendors such as Beckman Coulter and Sysmex. High order volumes among such vendors are ensured through established relationships with premium clients such as care networks, other large healthcare institutions, clinical laboratories, and reference labs. The profile of companies such as Beckman Coulter and Abbott Diagnostics is also higher due to the breadth of their product offering, particularly within the core lab - clinical chemistry, immunodiagnostics, and hematology. Also aiding a company such as Beckman Coulter is its corporate history in the development of modern laboratory hematology. The focus on industry leaders is not undue, but forming a synopsis based on those vendors alone limits the analysis and scope of the global hematology market.

The recent changing of the guard in hematology leadership reveals a source of market growth otherwise obscured by the calcified top industry tier. By 2009, Sysmex claimed industry-leading revenue in laboratory hematology with a broad product line appealing to labs with widely varying hematology testing volumes. Sysmex’s aggressive marketing also allowed the company to expand into once more peripheral markets such as North America and Asia. The Japanese company now holds a geographically diversified revenue base with a strong position in its home market of Japan, presence in Europe, and most importantly rising market shares in the Americas and Asia. In China and India, Sysmex has participated in the expansion and modernization of clinical care by supplying competitively priced and flexible hematology platforms.

The participation of Sysmex and other hematology leaders in markets outside of North America, Europe and Japan (Rest of the World; ROW) calls into question the extent and value of such markets. While they are not neglected, ROW markets still represent an unknown in the global hematology market. Countries such as India, China and their neighbors are served by a galaxy of low-grossing local manufacturers and small OEM operations that remain overshadowed by the distribution activities of major IVD vendors. Evident from research into clinical testing rates and industry mapping of smaller hematology players, ROW countries represent substantial markets - and are key to determining the boundaries and total size of the global hematology market.

Kalorama Information’s upcoming report on the global hematology market will address the questions prompted above - namely what amount of additional revenue is realized beyond the roughly $2.5 billion held by major vendors, and what products fill the relative role of laboratory hematology in the smaller labs and clinics of developing and ROW markets.